Patents
Patents for C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
07/2005
07/21/2005DE10359026A1 Verfahren zur Herstellung von Tetrahydrogeranylaceton A process for preparing tetrahydrogeranylacetone
07/21/2005CA2549385A1 Triazole, oxadiazole and thiadiazole derivative as ppar modulators for the treatment of diabetes
07/21/2005CA2549330A1 Calcitonin gene related peptide receptor antagonists
07/20/2005EP1554259A1 Novel bicyclic inhibitors of hormone sensitive lipase
07/20/2005EP1268396B1 Diphenyl ether compounds useful in therapy
07/20/2005EP1173425B1 (-)-enantiomer of the 2- 2-(1- chlorocyclopropyl)-3- (2-chlorophenyl) -2- hydroxypropyl] -2,4- dihydro- 1,2,4] -triazole -3-thione
07/20/2005CN1642948A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
07/20/2005CN1642912A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
07/20/2005CN1642907A Carbonylamino-derivatives as novel inhibitors of histone deacetylase
07/20/2005CN1642551A Inhibitors of histone deacetylase
07/20/2005CN1642522A Uv absorber compositions comprising a hydroxyphenyltriazine compound
07/19/2005US6919363 Central nervous system disorders; antiischemic agents; analgesics
07/14/2005WO2005063689A1 Benzamide derivative
07/14/2005WO2005063239A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders
07/14/2005US20050154039 5-Sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
07/14/2005US20050154038 bicyclo[2.2.2]-oct-1-yl-1,2,4-triazoles; type 2 diabetes, lipid disorders, obesity, atherosclerosis, metabolic syndrome, hyperglycemia, insulin resistance; increase insulin sensitivity in muscle, liver and adipose tissue by correction of the elevated plasma levels of glucose without causing hypoglycemia
07/14/2005US20050153972 Triazole compounds
07/14/2005US20050153366 Protein-protein interaction antagonist screening libraries based upon 1,4-disubstituted naphthalenes and related scaffolds
07/14/2005CA2550649A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders
07/14/2005CA2550435A1 Azabicyclic heterocycles as cannabinoid receptor modulators
07/14/2005CA2550375A1 Azabicyclic heterocycles as cannabinoid receptor modulators
07/13/2005EP1553085A1 Cyclic amine derivatives and their use as drugs
07/13/2005EP1551810A1 Diaryl-substituted cyclic urea derivatives having an mch-modulatory effect
07/13/2005EP1551799A1 Cyclohexyl sulphones as gamma-secretase inhibitors
07/13/2005EP1551797A1 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors
07/13/2005EP1551795A1 Inhibitors of histone deacetylase
07/13/2005CN1639133A Novel antibacterial compounds, process for their preparation and pharmaceutical compositions containing them
07/13/2005CN1639125A New inhibitors of histone deacetylase
07/13/2005CN1636986A Benzophenones as inhibitors of reverse transcriptase
07/13/2005CN1636985A Benzophenones as inhibitors of reverse transcriptase
07/13/2005CN1636984A Benzophenones as inhibitors of reverse transcriptase
07/13/2005CN1636976A Mutilin derivatives and their use as antibacterials
07/13/2005CN1210582C Method for making contact lenses having UV absorbing properties
07/12/2005US6916867 Such as a hydroxybenzophenone and a 2-hydroxyphenylbenzotriazole and high density polyethylene or polyethylene of the metallocene type
07/12/2005US6916850 Pyruvate derivatives
07/12/2005US6916848 Compounds for the treatment of metabolic disorders
07/12/2005US6916813 (1-phenyl-2-heteoaryl)ethyl-guanidine compounds as inhibitors of mitochondrial F1F0 ATP hydrolase
07/12/2005US6916797 α-arylethylpiperazine derivatives as neurokinin antagonists
07/12/2005CA2238859C Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
07/07/2005WO2005061443A2 Benzoyl-substituted phenylalanine amides
07/07/2005US20050148778 One pot, industrial scale, low cost synthesis; forming diazonium salt of 4-[1,2,4]triazol-1ylmethyl-aniline HCL, reducing, acidifying; reacting intermediate with keto-valerolactone then fischer indole converting followed by transesterification, amination, saponification decarboxylation
07/07/2005US20050147633 Insecticidal amides with nitrogen-containing benzo-Fused bicyclic ring systems
07/07/2005DE10356579A1 Aminderivate Amine derivatives
07/07/2005CA2549184A1 6-(aminocarbonyl-phenyl) triazolopyrimidines, methods for the production thereof, use thereof for controlling harmful fungi, and substances containing the same
07/07/2005CA2548442A1 Benzoyl-substituted phenylalanine amides
07/06/2005EP1549623A2 Process for preparing 3-chloromethyl-1,2,4-triazolin-5-one
07/06/2005EP1549600A1 Ketones
07/06/2005CN1635979A IL-8 receptor antagonists
07/06/2005CN1635911A Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors
07/05/2005US6914086 Crosslinkable UV absorbing agent for UV absorbing lens
07/05/2005US6914058 1-(p-(thiomorpholino)phenyl)-1,2,3-triazole derivatives
06/2005
06/30/2005WO2005058868A1 N-(4-carbamimidoyl-benzyl) -2-alkoxy-2-heterocyclyl acetamides as inhibitors of the formation of coagulation factors xa, ixa and thrombin induced by factor viia
06/30/2005WO2005058844A2 Novel compounds which are modulators of the ppar-type receptors and their use in cosmetic or pharmaceutical compositions
06/30/2005WO2005058840A2 Method of coloring with capped diazotized compound and coupling component
06/30/2005WO2005058832A1 Diacylhydrazine derivatives
06/30/2005WO2005058808A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
06/30/2005US20050143584 Antiozonant based on functionalized benzotriazole UV absorbers and the process thereof
06/30/2005US20050143578 Compounds and methods
06/30/2005US20050143426 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion
06/30/2005CA2549825A1 N-(4-carbamimidoyl-benzyl) -2-alkoxy-2-heterocyclyl acetamides as inhibitors of the formation of coagulation factors xa, ixa and thrombin induced by factor viia
06/30/2005CA2549598A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
06/30/2005CA2548571A1 Diacylhydrazine derivatives
06/30/2005CA2545767A1 Novel compounds which are modulators of the ppar-type receptors and their use in cosmetic or pharmaceutical compositions
06/29/2005EP1546158A1 Azole derivatives as antifungal agents
06/29/2005EP1546089A2 Aryl and heteroaryl compounds and methods to modulate coagulation
06/29/2005EP1545483A2 Non-nucleoside reverse transcriptase inhibitors
06/29/2005CN1208327C Process for preparing S, Síõ-carbonyl disulfhydryl substituted five-membered heterocyclic compound
06/29/2005CN1208321C Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
06/28/2005US6911469 For therapy of disease treatable based on a blood sugar level-depressing activity or a disease treatable based on a cGMP-PDE inhibiting activity, smooth muscle relaxing activity, bronchodilating activity, vasodilating activity
06/28/2005US6911439 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents
06/28/2005CA2114746C Substituted triazolinones
06/23/2005WO2005057171A2 Protein-protein interaction antagonist screening libraries based upon 1,4-disubstituted naphthalenes and related scaffolds
06/23/2005WO2005056535A1 1,2,3-triazole amide derivatives as inhibitors of cytokine production
06/23/2005WO2005056508A1 Method for the production of tetrahydrogeranylacetone
06/23/2005WO2005055940A2 Novel m3 muscarinic acetylcholine receptor antagonists
06/23/2005US20050137168 inhibit the formation of coagulation factors Xa, IXa and thrombin induced by factor VIIa and tissue factor; for treatment and/or prevention of arterial and venous thrombosis, deep vein thrombosis, pulmonary embolism, unstable angina pectoris, cardiac infarction, stroke
06/23/2005CA2549272A1 Novel m3 muscarinic acetylcholine receptor antagonists
06/23/2005CA2548262A1 Method for the production of tetrahydrogeranylacetone
06/23/2005CA2547410A1 1,2,3-triazole amide derivatives as inhibitors of cytokie production
06/22/2005EP1542990A1 Novel imidazole compounds as transforming growth factor (tgf) inhibitors
06/22/2005EP1542678A1 1H-1,2,4-TRIAZOLE-3-CARBOXAMIDE DERIVATIVES AS CANNABINOID-CB sb 1 /sb RECEPTOR LIGANDS
06/22/2005EP1100763B1 Diketoacid-derivatives as inhibitors of polymerases
06/22/2005EP1082127B1 Succinamide inhibitors of interleukin-1beta converting enzyme
06/22/2005CN1630646A Optically active azole derivative and process for producing the same
06/22/2005CN1630519A Use of anastrozole for the treatment of post-menopausal women having early breast cancer
06/22/2005CN1207289C Metalloproteinase inhibitors, pharmaceutical compositions containing the same and their pharmaceutical uses, and methods and intermediates useful for their preparation
06/21/2005US6908938 Heterocyclic aromatic compounds useful as growth hormone secretagogues
06/21/2005US6908935 Calcium receptor modulating agents
06/16/2005WO2005054246A2 Amine derivatives having a tyrosine-kinase-inhibiting effect
06/16/2005WO2005054212A2 Electroluminescent device
06/16/2005WO2005053631A1 Microcapsules with uv filter activity and process for producing them
06/16/2005US20050131041 Using trizole or imidazole compound containing hydroxy group
06/16/2005US20050130940 Fungal infections; water soluble phosphate derivatives of triazole drugs such as fluconazole
06/16/2005US20050130843 Substituted thien-3-yl-sulphonylamino(thio)carbonyl-triazolin(ethi)ones
06/16/2005US20050129632 Benzotriazoles, dibenzoylmethane derivatives and camphor derivatives: Ultraviolet filters in cosmetic compositions
06/16/2005CA2547248A1 Process for preparing substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines
06/15/2005EP1539760A2 Azapurine derivatives
06/15/2005EP1539719A1 Organic compounds
06/15/2005EP1539718A1 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
06/15/2005EP1539717A2 Microbiocidal (e.g fungicidal) 1,2,3-triazole derivatives
1 ... 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 ... 178